Effectiveness and cost-effectiveness of an electronic mindfulness-based intervention (eMBI) on maternal mental health during pregnancy: the mindmom study protocol for a randomized controlled clinical trial.
Journal
Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253
Informations de publication
Date de publication:
17 Nov 2020
17 Nov 2020
Historique:
received:
13
06
2020
accepted:
04
11
2020
entrez:
18
11
2020
pubmed:
19
11
2020
medline:
22
6
2021
Statut:
epublish
Résumé
Mental disorders are common during the peripartum period and may have far-reaching consequences for both mother and child. Unfortunately, most antenatal care systems do not provide any structured screening for maternal mental health. As a consequence, mental illnesses are often overlooked and not treated adequately. If correctly diagnosed, cognitive behavioral therapy is currently the treatment of choice for mental illnesses. In addition, mindfulness-based interventions (MBIs) seem to represent a promising treatment option for anxiety and depression during the peripartum period. Considering the internet's increasing omnipresence, MBIs can also be offered electronically via a (tablet) computer or smartphone (electronically based MBI = eMBI). The current study aims to examine the clinical effectiveness and cost-effectiveness of an eMBI (the mindmom application) developed by an interdisciplinary team of gynecologists, psychologists, and midwives, teaching pregnant women how to deal with stress, pregnancy-related anxiety, and depressive symptoms. The study sample consists of pregnant women in their third trimester who screened positive for emotional distress. The mindmom study is a bicentric prospective randomized controlled trial (RCT), which is currently conducted at the University women's hospitals of Heidelberg and Tübingen, Germany. Within the scope of the routine prenatal care, pregnant women attending routine pregnancy care in Baden-Wuerttemberg, Germany, are invited to participate in a screening for mental distress based on the Edinburgh Postnatal Depression Scale (EPDS). Women with an EPDS screening result > 9 will be referred to one of the mindmom coordinating study centers and are offered counseling either face-to-face or via videotelephony. After an initial psychological counseling, women are invited to participate in an eMBI in their last pregnancy trimester. The study will enroll N = 280 study participants (N = 140 per group), who are randomized 1:1 into the intervention (IG) or control group (treatment as usual = TAU). All participants are requested to complete a total of 7 digital assessments (5 visits pre- and 2 follow-up visits postpartum), involving self-report questionnaires, sociodemographic and medical data, physiological measures, and morning cortisol profiles. The primary outcome will be depressive and anxiety symptoms, measured by the Edinburgh Postnatal Depression Scale, the State Trait Anxiety Questionnaire, and the Pregnancy-Related Anxiety Questionnaire. Secondary outcomes include mindfulness, satisfaction with birth, quality of life, fetal attachment, bonding, mode of delivery, and cost-effectiveness. This is the first German RCT to examine the (cost-)effectiveness of an eMBI on maternal mental health during pregnancy. If successful, the mindmom app represents a low-threshold and cost-effective help for psychologically distressed women during pregnancy, thereby reducing the negative impact on perinatal health outcome. Deutsches Register Klinischer Studien, German Clinical Trials Register DRKS00017210 . Registered on 13 January 2020. Retrospectively registered.
Sections du résumé
BACKGROUND
BACKGROUND
Mental disorders are common during the peripartum period and may have far-reaching consequences for both mother and child. Unfortunately, most antenatal care systems do not provide any structured screening for maternal mental health. As a consequence, mental illnesses are often overlooked and not treated adequately. If correctly diagnosed, cognitive behavioral therapy is currently the treatment of choice for mental illnesses. In addition, mindfulness-based interventions (MBIs) seem to represent a promising treatment option for anxiety and depression during the peripartum period. Considering the internet's increasing omnipresence, MBIs can also be offered electronically via a (tablet) computer or smartphone (electronically based MBI = eMBI).
OBJECTIVE
OBJECTIVE
The current study aims to examine the clinical effectiveness and cost-effectiveness of an eMBI (the mindmom application) developed by an interdisciplinary team of gynecologists, psychologists, and midwives, teaching pregnant women how to deal with stress, pregnancy-related anxiety, and depressive symptoms. The study sample consists of pregnant women in their third trimester who screened positive for emotional distress. The mindmom study is a bicentric prospective randomized controlled trial (RCT), which is currently conducted at the University women's hospitals of Heidelberg and Tübingen, Germany.
METHODS
METHODS
Within the scope of the routine prenatal care, pregnant women attending routine pregnancy care in Baden-Wuerttemberg, Germany, are invited to participate in a screening for mental distress based on the Edinburgh Postnatal Depression Scale (EPDS). Women with an EPDS screening result > 9 will be referred to one of the mindmom coordinating study centers and are offered counseling either face-to-face or via videotelephony. After an initial psychological counseling, women are invited to participate in an eMBI in their last pregnancy trimester. The study will enroll N = 280 study participants (N = 140 per group), who are randomized 1:1 into the intervention (IG) or control group (treatment as usual = TAU). All participants are requested to complete a total of 7 digital assessments (5 visits pre- and 2 follow-up visits postpartum), involving self-report questionnaires, sociodemographic and medical data, physiological measures, and morning cortisol profiles. The primary outcome will be depressive and anxiety symptoms, measured by the Edinburgh Postnatal Depression Scale, the State Trait Anxiety Questionnaire, and the Pregnancy-Related Anxiety Questionnaire. Secondary outcomes include mindfulness, satisfaction with birth, quality of life, fetal attachment, bonding, mode of delivery, and cost-effectiveness.
DISCUSSION
CONCLUSIONS
This is the first German RCT to examine the (cost-)effectiveness of an eMBI on maternal mental health during pregnancy. If successful, the mindmom app represents a low-threshold and cost-effective help for psychologically distressed women during pregnancy, thereby reducing the negative impact on perinatal health outcome.
TRIAL REGISTRATION
BACKGROUND
Deutsches Register Klinischer Studien, German Clinical Trials Register DRKS00017210 . Registered on 13 January 2020. Retrospectively registered.
Identifiants
pubmed: 33203471
doi: 10.1186/s13063-020-04873-3
pii: 10.1186/s13063-020-04873-3
pmc: PMC7672841
doi:
Types de publication
Clinical Trial Protocol
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
933Subventions
Organisme : Federal Joint Commitee (G-BA)
ID : 01NVF17034
Références
Acta Obstet Gynecol Scand. 2003 Mar;82(3):201-8
pubmed: 12694113
Neurosci Biobehav Rev. 2005 Apr;29(2):237-58
pubmed: 15811496
Clin Psychol Rev. 2018 Feb;59:52-60
pubmed: 29126747
BMC Psychiatry. 2015 Aug 25;15:206
pubmed: 26303960
Arch Womens Ment Health. 2006 Sep;9(5):233-42
pubmed: 16673041
Arch Womens Ment Health. 2006 Sep;9(5):265-71
pubmed: 16937316
Infant Behav Dev. 2006 Jul;29(3):445-55
pubmed: 17138297
J Affect Disord. 2016 Jan 15;190:543-550
pubmed: 26571104
J Consult Clin Psychol. 2010 Apr;78(2):169-83
pubmed: 20350028
J Consult Clin Psychol. 2016 Feb;84(2):134-45
pubmed: 26654212
Scand J Prim Health Care. 2017 Jun;35(2):126-136
pubmed: 28585868
J Clin Epidemiol. 2010 Aug;63(8):e1-37
pubmed: 20346624
Behav Res Methods. 2009 Nov;41(4):1149-60
pubmed: 19897823
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Clin Psychol Rev. 2013 Aug;33(6):763-71
pubmed: 23796855
Arch Womens Ment Health. 2015 Dec;18(6):829-32
pubmed: 25577338
Clin Psychol Rev. 2017 Jul;55:74-91
pubmed: 28501707
J Anxiety Disord. 2018 Apr;55:70-78
pubmed: 29422409
Age Ageing. 2014 May;43(3):334-41
pubmed: 24333802
Arch Womens Ment Health. 2014 Oct;17(5):373-87
pubmed: 24449191
Arch Gen Psychiatry. 1995 May;52(5):374-83
pubmed: 7726718
Infant Behav Dev. 2012 Apr;35(2):264-72
pubmed: 22261433
Psychother Psychosom Med Psychol. 2019 Oct;69(9-10):407-412
pubmed: 30731509
Arch Gynecol Obstet. 2019 Mar;299(3):755-763
pubmed: 30734864
Arch Womens Ment Health. 2008 Jul;11(3):239-48
pubmed: 18493710
Can J Clin Pharmacol. 2009 Winter;16(1):e15-22
pubmed: 19164843
Early Hum Dev. 2004 Sep;79(2):81-91
pubmed: 15324989
Biometrics. 1989 Sep;45(3):1017-20
pubmed: 2790114
Early Hum Dev. 2004 Jun;78(1):15-27
pubmed: 15177669
Health Psychol Rev. 2014;8(1):70-94
pubmed: 24489596
Cogn Behav Ther. 2009;38(4):196-205
pubmed: 20183695
Br J Psychiatry. 1987 Jun;150:782-6
pubmed: 3651732
Behav Res Methods. 2007 May;39(2):175-91
pubmed: 17695343
Psychosom Med. 2006 Nov-Dec;68(6):931-7
pubmed: 17132840
Int J Nurs Stud. 2012 Jan;49(1):109-21
pubmed: 21963234
Nurs Res. 1981 Sep-Oct;30(5):281-4
pubmed: 6912989
Arch Womens Ment Health. 2018 Apr;21(2):149-161
pubmed: 29022126
Birth. 2009 Mar;36(1):60-9
pubmed: 19278385
JAMA Psychiatry. 2013 May;70(5):490-8
pubmed: 23487258
J Affect Disord. 2014 Apr;159:103-10
pubmed: 24679397
J Affect Disord. 2016 Mar 1;192:83-90
pubmed: 26707352
Arch Womens Ment Health. 2013 Oct;16(5):363-9
pubmed: 23558948
Arch Womens Ment Health. 2015 Apr;18(2):187-195
pubmed: 25088531
Psychoneuroendocrinology. 2012 Dec;37(12):2037-41
pubmed: 22626868
Dtsch Med Wochenschr. 1998 Jan 16;123(3):35-40
pubmed: 9472218
Psychoneuroendocrinology. 2016 Jan;63:414-32
pubmed: 26563991
Matern Child Health J. 2014 Oct;18(8):1873-80
pubmed: 24474591